EDX Medical, a provider of health testing solutions, agreed to go public via merger with TECC Capital, a special purpose acquisition company, in a £12m deal. "I am delighted to announce the proposed acquisition of EDX and an associated Placing. EDX, an ambitious pioneer in digital diagnostics, is a dynamic business, led by a strong management team with a proven track record in growing SME businesses in the biotechnology sector, which the Directors believe is capable of signifcant growth. We believe the Acquisition presents the Company and our Shareholders with an exciting opportunity to invest in a new and disruptive biotechnology business with signifcant potential," Sandy Barblett, TECC Capital Chairman.